NASDAQ: CYTK · Biotechnology
Over the past week, Cytokinetics (CYTK) pulled in about 32 mentions across Reddit, X and news, and the read is an Adanos Hold. The crowd averages 54% bullish but is sharply divided: News runs 78% bullish while X sits at just 34%. Wall Street is more constructive, with 20 of 22 analysts rating CYTK a buy.
There is little buzz around CYTK this week and little agreement on direction, which is why it reads as a Hold.
Wall Street’s 91% buy share sits next to a crowd that ranges from X at 34% to News at 78%. No other tracker puts the two side by side.
22 analysts have weighed in: a Strong Buy consensus: 20 buy calls against 0 sell, with an average 12-month price target of $109.90.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits above the neutral line, momentum is improving and the 3 sources disagree sharply, so the read is Hold rather than a clear buy or sell.
Analysts sit 37 points above the crowd average of 54%, the professionals are more constructive than retail. The split is inside the crowd: News reads 78% bullish while X sits at 34%, a 44-point spread that single-source trackers miss.
Over the 30-day window, Cytokinetics (CYTK) buzz held subdued around 22.5 while the price drifted down 10.6% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 1.9M shares. Over the last 7 trading days, CYTK lost 6.6%. Buzz activity in the recent week averaged 30.0 and was variable, swinging between 14.0 and 53.5. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 9 of the 17 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for CYTK and 2001+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live CYTK sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Sep 04, 2026.
| Adanos signal | Hold |
|---|---|
| Analyst consensus | Strong Buy (20 / 2 / 0) |
| Crowd bullish (7d) | 54% |
| Avg price target | $109.90 |
| Most bullish source | News, 78% |
| Most bearish source | X, 34% |
| Sentiment spread | 44 pts |
| Mentions (7d) | 32 |
| Market cap | $10.28B |
| P/E · Forward P/E | n/a · 117.7 |
| EPS · Beta | -$7.22 · 0.4 |
| Revenue (TTM) | $67.7M · 0% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Cytokinetics (CYTK) currently carries an Adanos hold signal with 67/100 conviction. The current cross-source average reads 54% bullish across 3 active sources. Those sources contribute 32 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Cytokinetics (CYTK) is fairly quiet with 2 mentions over the last 7 days; the 30-day context spans 1 tracked subreddits. The 7-day tone is 50% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads split on Cytokinetics (CYTK), averaging 54% bullish across 3 tracked sources over the last 7 days. The two ends of the range are News at 78% bullish and X at 34%, a 44-point spread. On the professional side, 20 of 22 analysts rate CYTK a buy.
Of the 22 analysts covering Cytokinetics (CYTK), 20 rate it a buy, 2 a hold and 0 a sell, for a strong buy consensus. The average price target is $109.90. That puts the street ahead of the crowd, which averages 54% bullish.
Cytokinetics (CYTK)'s cross-source average is mixed at 54% bullish. Source readings are split: 1 source leans bullish, 1 source leans bearish and 1 source sits at 50% bullish. Reddit reads 50% bullish, News reads 78% bullish and x coverage is the most negative at 34% bullish. The combined signal points to broad mixed pressure with 67/100 conviction.
The cross-source average is mixed for Cytokinetics (CYTK) at 54% bullish. Source readings are split: 1 source leans bullish, 1 source leans bearish and 1 source sits at 50% bullish. The most bearish reading is x at 34% bullish. 3-day activity momentum is rising across X and News. The hold signal carries 67/100 conviction.
X is the dominant discussion channel with 21 mentions (66% of total volume). News contributes 9 mentions and Reddit contributes 2 mentions. The cross-source average is mixed at 54% bullish, while x and news show rising 3-day activity. Source readings are split: 1 source leans bullish, 1 source leans bearish and 1 source sits at 50% bullish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. CYTK's hold signal at 67/100 conviction reflects a mixed cross-source average at 54% bullish. Source readings are split: 1 source leans bullish, 1 source leans bearish and 1 source sits at 50% bullish. It is a research shortcut, not financial advice.
The CYTK sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Hold signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key